淺談胃癌微創手術治療

Minimal Invasive Surgery for Gastric Cancer

10.6880/TJON.202012_20(2).03

李京錞(Ching-Chun Li)；王照元(Jaw-Yuan Wang)

胃癌 ； 腹腔鏡胃癌切除手術 ； 達文西機械手臂胃癌切除手術 ； stomach cancer ； laparoscopic gastrectomy ； robotic gastrectomy

腫瘤護理雜誌

20卷2期（2020 / 12 / 01）

17 - 20

繁體中文

胃癌是世界上第五名常見的癌症，在台灣為國人癌症發生率的第十位。治療方式會根據臨床分期、腫瘤部位、病人本身因素來決定，包括經內視鏡腫瘤切除、外科手術切除、放射線治療、化學藥物治療、標靶藥物治療、以及最新的免疫藥物治療等。外科手術依據治療目標的不同，又可分為胃癌根治手術（radical）以及姑息性手術（palliative），而胃癌根治切除手術是目前首選且最有效的治療方式。透過手術方式，以完全切除癌組織且合併切除的組織邊緣沒有檢查出癌細胞的浸潤，還要有足夠範圍的淋巴腺廓清，包含胃周邊淋巴結和腹腔動脈血管旁淋巴結，以達到最佳的治療結果。

Stomach cancer is the fifth most common cancer in the world, and Taiwan ranks tenth in the incidence of cancer among Chinese people. The treatment method will be determined according to the clinical stage, tumor location, and the patient's own factors, including endoscopic tumor resection, surgical resection, radiation therapy, chemotherapy, targeted drug therapy, and the latest immunotherapy. Surgery can be divided into radical and palliative based on different treatment goals. Radical resection of gastric cancer is currently the preferred and most effective treatment. Through surgical methods, the cancer tissues are completely removed and the edges of the combined resection tissues are not detected for cancer infiltration, and there must be a sufficient range of lymph gland clearance, including lymph nodes around the stomach and paravascular lymph nodes of the celiac artery to achieve the best treatment result.

1. Bray, F.,Ferlay, J.,Soerjomataram, I.,Siegel, R. L.,Torre, L. A.,Jemal, A.(2018).Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.A Cancer Journal for Clinicians,68(6),394-424.
2. Hu, Y.,Huang, C.,Sun, Y.,Su, X.,Cao, H.,Hu, J.,Wei, H.(2016).Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: A randomized controlled trial.Journal of Clinical Oncology,34(12),1350-1357.
3. Inaki, N.,Etoh, T.,Ohyama, T.,Uchiyama, K.,Katada, N.,Koeda, K.,Shiraishi, N.(2015).A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901).World Journal of Surgery,39(11),2734-2741.
4. Japanese Gastric Cancer Association(2020).Japanese gastric cancer treatment guidelines 2018 (5th edition).Gastric Cancer,1-21.
5. Lee, H. J.,Hyung, W. J.,Yang, H. K.,Han, S. U.,Park, Y. K.,An, J. Y.,Hur, H.(2019).Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT).Annals of Surgery,270(6),983-991.
6. National Comprehensive Cancer Network (2020). Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Gastric Cancer. Version 3. Available online: https://www.nccn.org/store/login/login.aspx?ReturnURL= https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed on 8 September 2020)
7. Uyama, I.,Suda, K.,Nakauchi, M.,Kinoshita, T.,Noshiro, H.,Takiguchi, S.,Terashima, M.(2019).Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: A multi-institutional prospective single-arm study.Gastric Cancer,22(2),377-385.
8. Yu, J.,Huang, C.,Sun, Y.,Su, X.,Cao, H.,Hu, J.,Wei, H.(2019).Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: The CLASS-01 randomized clinical trial.JAMA,321(20),1983-1992.
9. 衛生福利部國民健康署（2020，12月29日 ）．107年癌症登記報告．取自https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269&pid=13498

1. (2024)。應用希望理論於照顧一位胃癌腸阻塞併COVID-19感染之護理經驗。腫瘤護理雜誌，24(1)，89-99。